233 related articles for article (PubMed ID: 26202817)
21. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
[TBL] [Abstract][Full Text] [Related]
22. The rate of invasive testing for trisomy 21 is reduced after implementation of NIPT.
Bjerregaard L; Stenbakken AB; Andersen CS; Kristensen L; Jensen CV; Skovbo P; Sørensen AN
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385172
[TBL] [Abstract][Full Text] [Related]
23. Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay.
Verweij EJ; Oepkes D; de Vries M; van den Akker ME; van den Akker ES; de Boer MA
Patient Educ Couns; 2013 Dec; 93(3):641-5. PubMed ID: 24011429
[TBL] [Abstract][Full Text] [Related]
24. Improving women's knowledge about prenatal screening in the era of non-invasive prenatal testing for Down syndrome - development and acceptability of a low literacy decision aid.
Smith SK; Cai A; Wong M; Sousa MS; Peate M; Welsh A; Meiser B; Kaur R; Halliday J; Lewis S; Trevena L; Yanes T; Barlow-Stewart K; Barclay M
BMC Pregnancy Childbirth; 2018 Dec; 18(1):499. PubMed ID: 30558569
[TBL] [Abstract][Full Text] [Related]
25. The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access.
Birko S; Ravitsky V; Dupras C; Le Clerc-Blain J; Lemoine ME; Affdal AO; Haidar H; Laberge AM
BMC Pregnancy Childbirth; 2019 Jan; 19(1):22. PubMed ID: 30630440
[TBL] [Abstract][Full Text] [Related]
26. Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results.
van Schendel RV; Page-Christiaens GCML; Beulen L; Bilardo CM; de Boer MA; Coumans ABC; Faas BHW; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MVE; Oepkes D; Pajkrt E; Henneman L;
J Genet Couns; 2017 Dec; 26(6):1348-1356. PubMed ID: 28667567
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
[TBL] [Abstract][Full Text] [Related]
28. Applicability of first-trimester combined screening for fetal trisomy 21 in a resource-limited setting in mainland China.
Li B; Sahota DS; Lao TT; Xu J; Hu SQ; Zhang L; Liu QY; Sun Q; Tang D; Ma RM
BJOG; 2016 Sep; 123 Suppl 3():23-9. PubMed ID: 27627592
[TBL] [Abstract][Full Text] [Related]
29. Second tier non-invasive prenatal testing in a regional prenatal diagnosis service unit: a retrospective analysis and literature review.
Ng VKS; Chan AL; Lau WL; Leung WC
Hong Kong Med J; 2020 Feb; 26(1):10-18. PubMed ID: 32051331
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive prenatal testing: A diagnostic innovation shaped by commercial interests and the regulation conundrum.
Löwy I
Soc Sci Med; 2022 Jul; 304():113064. PubMed ID: 32534823
[TBL] [Abstract][Full Text] [Related]
31. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center.
Manegold-Brauer G; Berg C; Flöck A; Rüland A; Gembruch U; Geipel A
Arch Gynecol Obstet; 2015 Sep; 292(3):543-8. PubMed ID: 25716672
[TBL] [Abstract][Full Text] [Related]
32. Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.
Ngan OMY; Yi H; Ahmed S
BMC Health Serv Res; 2018 Sep; 18(1):731. PubMed ID: 30241520
[TBL] [Abstract][Full Text] [Related]
33. The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis.
Sebire E; Rodrigo CH; Bhattacharya S; Black M; Wood R; Vieira R
PLoS One; 2024; 19(5):e0298643. PubMed ID: 38753891
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.
Song K; Musci TJ; Caughey AB
J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1180-5. PubMed ID: 23356557
[TBL] [Abstract][Full Text] [Related]
35. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.
Kater-Kuipers A; Bunnik EM; de Beaufort ID; Galjaard RJH
BMC Pregnancy Childbirth; 2018 Oct; 18(1):409. PubMed ID: 30340550
[TBL] [Abstract][Full Text] [Related]
36. Uptake of Noninvasive Prenatal Testing in Chinese Women following Positive Down Syndrome Screening.
Poon CF; Tse WC; Kou KO; Leung KY
Fetal Diagn Ther; 2015; 37(2):141-7. PubMed ID: 25342109
[TBL] [Abstract][Full Text] [Related]
37. Decision outcomes in women offered noninvasive prenatal test (NIPT) for positive Down screening results.
Lo TK; Chan KY; Kan AS; So PL; Kong CW; Mak SL; Lee CN
J Matern Fetal Neonatal Med; 2019 Jan; 32(2):348-350. PubMed ID: 28927326
[TBL] [Abstract][Full Text] [Related]
38. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
[TBL] [Abstract][Full Text] [Related]
40. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
